Financial Daily from THE HINDU group of publications
Sunday, Oct 31, 2004
Financial Daily from THE HINDU group of publications Sunday, Oct 31, 2004 |
||
|
|
||
|
Corporate
-
Announcements Aurobindo gets USFDA nod Our Bureau
HYDERABAD: Aurobindo Pharma Ltd (APL), the Hyderabad-based pharmaceutical company, has announced that it has obtained the United States Food & Drug Administration (USFDA) nod for its first new abbreviated drug application (ANDA) on Citalopram. The development comes close on the heels of the company having obtained the USFDA approval for its first ANDA on Mirtazapine last week. In a press release here, the company said the approval for Citalopram made it occupy the position among the first lot and reflected the quality of its filings and manufacturing facilities. The company has incurred an additional Rs 21 crore of expenditure on regulatory filings, bio-studies and related plant expenses. These investments would reflect in rapid ANDA filings and concomitant revenues from regulated markets over the medium-term.
More Stories on : Announcements | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|